Introduction
The regulation of artificial intelligence (AI) medical devices has become a pressing issue. The US Food and Drug Administration (FDA) has adopted a firm-based approach for regulating lower-risk
When you partner with Syenza, it’s like a Nuclear Fusion.
Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in
health policy, health economics, systems analysis, public finance, business, and project management.
You’ll also feel our high-impact global and local perspectives with cultural intelligence.